Lisa Stewart

Patients who are blind from retinitis pigmentosa continue to benefit from a safe retinal implant after 3 years, Ophthalmology reported

Patients who are blind from retinitis pigmentosa continue to benefit from a safe retinal implant after 3 years, Ophthalmology reported

Retinal microglia contribute to rod demise in retinitis pigmentosa-a blinding hereditary retinal disease for which there is currently no approved treatment, according to a recent study.

Gene therapy to treat choroideremia is one step closer to reality thanks to a new study.

Patients with symptomatic vitreomacular adhesion (VMA) find that a single intravitreal injection of ocriplasmin improves their vision, according to an ancillary analysis of two multicentre randomised clinical trials reported in JAMA Opthalmology.

Google Glass may be the answer for retina surgeons who struggle to record scleral buckling surgery, according to a recent study published in JAMA Ophthalmology.